Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator.

Implantable cardioverter-defibrillator in a patient with dextrocardia situs inversus

Background: Dextrocardia is a congenital anomaly, which may have coexistent coronary artery disease (CAD), arrhythmias and conventional indications for device therapy. However, the implantation of transvenous leads can be technically challenging and the approach needs to be tailored to the patient's individual anatomy. Case presentation: A 54-year-old male with dextrocardia situs inversus and i...

THE EFFECT OF NURSE-PEER-LED SUPPORT INTERVENTION ON QUALITY OF LIFE IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A RANDOMIZED CLINICAL TRIAL

Background & Aims: Nowadays, the quality of life and how coping and treatment of patients with an implantable cardiac defibrillator has led to concern and attempts to reduce or eliminate the problems of these patients in the people who provide health care services. This study aimed to determine the effect of nurse-peer-led support intervention on quality of life in patients with an implantable ...

Use of implantable cardioverter defibrillators in patients with left ventricular assist devices.

Patients with left ventricular assist devices (LVADs) are at high risk of sustained ventricular arrhythmias, but these may be remarkably well tolerated and the association with sudden death is unclear. Many patients who receive an LVAD already have an implantable cardioverter defibrillator (ICD). While it is standard practice to reactivate a previously implanted ICD in an LVAD recipient, this s...

Left ventricular assist device in a patient with a concomitant subcutaneous implantable cardioverter defibrillator.

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device

Advanced heart failure is the most frequent diagnosis in adult patients admitted to the hospital. The prevalence of heart failure has increased as options for treatment have improved. In addition to pharmacologic therapies, standard implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-D) have decreased mortality and improved quality of life. L...